WO2003094860A3 - Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome - Google Patents

Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome Download PDF

Info

Publication number
WO2003094860A3
WO2003094860A3 PCT/US2003/015081 US0315081W WO03094860A3 WO 2003094860 A3 WO2003094860 A3 WO 2003094860A3 US 0315081 W US0315081 W US 0315081W WO 03094860 A3 WO03094860 A3 WO 03094860A3
Authority
WO
WIPO (PCT)
Prior art keywords
c1orf28
hyperparathyroidism
diagnosis
homo sapiens
reading frame
Prior art date
Application number
PCT/US2003/015081
Other languages
French (fr)
Other versions
WO2003094860A2 (en
Inventor
John Carpten
Jeffrey Trent
Raman B Sood
Rajesh Thakker
Sunita K Agarwal
Bin Tean Teh
Catharina Larsson
Christiane Robbins
Original Assignee
Us Gov Health & Human Serv
Univ Duke
John Carpten
Jeffrey Trent
Raman B Sood
Rajesh Thakker
Sunita K Agarwal
Bin Tean Teh
Catharina Larsson
Christiane Robbins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Univ Duke, John Carpten, Jeffrey Trent, Raman B Sood, Rajesh Thakker, Sunita K Agarwal, Bin Tean Teh, Catharina Larsson, Christiane Robbins filed Critical Us Gov Health & Human Serv
Priority to AU2003232127A priority Critical patent/AU2003232127A1/en
Publication of WO2003094860A2 publication Critical patent/WO2003094860A2/en
Publication of WO2003094860A3 publication Critical patent/WO2003094860A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The present invention provides an isolated or purified oligonucleotide consisting essentially of the nucleotide sequence of Clorf28 and comprising a mutation; a fragment of the oligonucleotide; a vector comprising the oligonucleotide or fragment thereof; a cell comprising the vector; an isolated or purified polypeptide encoded by the above oligonucleotide or fragment thereof; a method of detecting HPT-JT or a predisposition to HPT-JT in a human, which method comprises detecting either at least one mutation in a nucleic acid comprising the nucleotide sequence of C1orf28 or a mutant C1orf28 protein; and an antibody which binds to a mutant C1orf28 protein.
PCT/US2003/015081 2002-05-13 2003-05-13 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome WO2003094860A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003232127A AU2003232127A1 (en) 2002-05-13 2003-05-13 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37802202P 2002-05-13 2002-05-13
US60/378,022 2002-05-13

Publications (2)

Publication Number Publication Date
WO2003094860A2 WO2003094860A2 (en) 2003-11-20
WO2003094860A3 true WO2003094860A3 (en) 2005-04-07

Family

ID=29420362

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/015081 WO2003094860A2 (en) 2002-05-13 2003-05-13 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome

Country Status (2)

Country Link
AU (1) AU2003232127A1 (en)
WO (1) WO2003094860A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005064346A2 (en) * 2003-12-22 2005-07-14 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of anti-parafibromin antibodies to diagnose hyperparathyroidism-jaw tumor syndrome (hpt-jt) and parathyroid cancer
WO2005095455A1 (en) * 2004-03-26 2005-10-13 Van Andel Research Institue Antibody specific for parafibromin, a new marker of parathyroid carcinoma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US6262557B1 (en) * 1997-08-06 2001-07-17 Matsushita Electric Industrial Co., Ltd. Motor with electronic distributing configuration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US6262557B1 (en) * 1997-08-06 2001-07-17 Matsushita Electric Industrial Co., Ltd. Motor with electronic distributing configuration

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARPTEN, J.D. ET AL.: "HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome", NATURE GENETICS, vol. 32, November 2002 (2002-11-01), pages 676 - 680, XP002984588 *
DATABASE NCBI [online] 12 September 2003 (2003-09-12), XP002984587, accession no. GENBANK Database accession no. AK026969 *
SOOD, R. ET AL.: "Clooning and Characterization of 13 Novel Transcripts and the Human RGS8 Gene from the 1q25 Region Encompassing the Hereditary Prostate Cancer (HPC1) Locus", GENOMICS, vol. 73, 2001, pages 211 - 222, XP002183732 *

Also Published As

Publication number Publication date
WO2003094860A2 (en) 2003-11-20
AU2003232127A1 (en) 2003-11-11
AU2003232127A8 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
WO2001023575A3 (en) Wuschel (wus) gene homologs
WO2003012046A3 (en) Stk15 (stk6) gene polymorphism and methods of determining cancer risk
SG134283A1 (en) Biomarkers for liver fibrotic injury
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
DE69808743D1 (en) Netrinrezeptoren
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2002032953A3 (en) Pregnancy-associated plasma protein-a2 (papp-a2)
CA2336236A1 (en) Mutations in and genomic structure of herg - a long qt syndrome gene
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
WO1998011234A3 (en) Human protein kinases
WO2000004162A3 (en) Genes encoding sulfate assimilation proteins
WO2003094860A3 (en) Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome
WO2002033046A3 (en) Glucose transport-related genes and uses thereof
Var et al. Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease
WO2000014239A3 (en) Thioredoxin h homologs
CA2628354A1 (en) Organic cation transporter genes
WO2001095860A3 (en) Probes for chondrogenesis
IL142755A0 (en) Mutation of the parkin gene, compositions, methods and uses
WO2000028036A3 (en) Disease resistance factors
MXPA01004353A (en) Chlamydia.
CA2367468A1 (en) Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2005507651A5 (en)
DE69940268D1 (en) CHLAMYDIA ANTIGEN, DNA FRAGMENTS WHICH CODE FOR SUCH AND USE THEREOF

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP